We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing

A scientist uses a pipette while wearing blue gloves. The image is overlaid with white dots and lines to represent a network.
Credit: iStock

Data-driven approaches are reshaping biopharmaceutical manufacturing. From optimizing cell culture media to enabling predictive control in perfusion bioreactors, scientists are applying statistical modeling and machine learning to boost productivity and ensure product quality.


This article explores how hybrid modeling frameworks and process-aware control systems are moving the industry beyond trial-and-error experimentation.


Continue reading to learn how experts are unlocking new efficiencies across the bioprocess lifecycle, driving smarter and more scalable biologics production.

Sponsored by

View this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.